John Joseph, former criminal prosecutor and Deputy Chief of the Civil Division at the U.S. Attorney’s Office in the Eastern District of Pennsylvania, is a partner in the Philadelphia-based law firm of Post & Schell, P.C., where he is part of its national practice in white collar defense, internal investigations and corporate compliance.
· Litigates complex corporate fraud and white collar cases, including “whistleblower” actions brought under the qui tam provisions of the False Claims Act,
· Conducts internal corporate investigations of alleged misconduct, consults on compliance plans, and helps clients respond to government investigations,
· Advises enterprises and individuals that are subject to government regulation on issues of compliance, corporate integrity agreements, and Sarbanes-Oxley requirements, and
· Defends enterprises, directors, officers and other professionals accused of misconduct at criminal or civil trials and on appeal.
Mr. Joseph has taught or lectured on white collar crime, the False Claims Act and trial advocacy at The Department of Justice’s National Advocacy Center, and has served as faculty for the National Institute for Trial Advocacy. He has also written and spoken on issues of fraud and compliance at programs hosted by the, AHLA-HCCA Fraud & Compliance Forum and the Pennsylvania Bar Institute. Mr. Joseph also serves as Co-Chair of AHLA’s Fraud and Abuse Enforcement Panel.
Post & Schell Pc
4 Penn Ctr
1600 Jfk Boulevard
Philadelphia, PA, 19103-2808
|Award name||Grantor||Date granted|
|Directors Award for Superior Performance||U.S. Department of Justice||2000|
|Silver Medal for Superior Service||U.S. Environmental Protection Agency||1999|
|Assistant U.S. Attorney||U.S. Attorney's Office, EDPA||1989 - 2005|
|Trial Attorney||U.S. Department Of Justice||1986 - 1989|
|Association name||Position name||Duration|
|American Health Lawyers Association||Member||2005 - Present|
|Journal of Health & Life Sciences Law, Vol. 5, No. 2 (February 2012)||Co-Author, "Is Sorrell the Death Knell for FDA's Off-Label Marketing Restrictions?"||2012|
|ALM Business Crimes Bulletin, Volume 17, Number 11||Government Overpayment: New Risks, New Exposures||2010|
|Journal of Health Care Compliance (CCH)||Internal Investigations by Health Care Organizations: What You Need to Know Before You Start||2006|
|University of Pennsylvania Law School||Doctor of Law (JD)||1986|
|University of Pennsylvania Law School||JD||N/A|
|HCCA's 18th Annual Compliance Institute||Voluntary Disclosure: When and Where,"||2014|
|Annual Meeting||"Lessons Learned from FirstPlus Financial RICO Defense Victory,"||2014|
|American Health Lawyers Association's (AHLA) Physicians and Hospitals Law Institute||"Complex Stark Implementation and Self-Disclosure,"||2014|
|2014 Developments in Pharmacy Law Seminar, Indian Wells, CA||"Mitigating False Claims Act and Consumer Protection Exposure for Retail Pharmacies,"||2014|
|The American Conference Institute's Advanced White Collar Summit||Advanced Summit on White Collar Litigation||2013|
|American Conference Institute's 12th Annual Summit on Reducing the Risks of Sales and Marketing of Medical Devices||"Managing, Defending and Curtailing Whistleblower Allegations Under an Expanded False Claims Act,"||2012|
|Institute of Internal Auditors 2010 Spring Conference||"One Thing You Have To Fear Is FERA Itself: Recent Amendments to the Federal False Claims Act and How They Will Impact Future Government Fraud Cases,"||2010|
|American Conference Institute’s 7th National Forum||"Off-Label Communications: Evaluating and Revamping Compliance Protocols in the Wake of Unprecedented Settlements;"||2010|
|U.S. v Scarfo||Not Guilty on all counts|
|Pappa v. Unum Life Ins. Co||Motion to Dismiss Granted|
Endorsements from fellow lawyers are an important consideration for many when selecting the right attorney. Be the first to endorse your colleague!